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SUMMARY
Introduction/Objective Spinal anesthesia (SA) for cesarean section may lead to significant changes in 
hemodynamic parameters, especially hypotension. 
The aim of this study was to determine and compare the efficacy and safety of preemptive infusion 
protocols of the two most commonly used vasopressors, ephedrine (Group E, n = 29) and phenylephrine 
(Group P, n = 31) not only on prevention of hypotension but also to determine their effect on hemody-
namic parameters, such as stroke volume (SV) and cardiac output (CO) using a continuous non-invasive 
hemodynamic monitor.
Methods The infusion of ephedrine was administered at the rate of 5 mg/min. immediately after SA. 
Phenylephrine was administered at an infusion rate of 25 μg/min for two minutes prior to SA.
Results In Group E, mean systolic blood pressure (SBP) and heart rate (HR) were similar to baseline. CO was 
higher (p < 0.001), while systemic vascular resistance (SVR) was lower than baseline (p < 0.001). In Group P, 
mean SBP and diastolic blood pressure (DBP) were lower than baseline, respectively (p = 0.006, p < 0.001). 
SBP, DBP, CO, SV, SVR, and HR were significantly different between the E and P groups (p < 0.001).
Conclusion E and P vasopressors are both effective in the prevention of hypotension during SA. 
Keywords: cesarean section; spinal anesthesia; ephedrine; phenylephrine; hypotension; hemodynamic 
parameters
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INTRODUCTION
Due to the significantly higher percentage of 
morbidity and mortality under general anesthe-
sia, spinal anesthesia (SA) is now the method of 
choice [1]. Cesarean section under SA leads to 
significant changes in hemodynamic param-
eters, such as preload, stroke volume (SV), car-
diac output (CO), heart rate (HR) and systemic 
vascular resistance (SVR) [2]. Hypotension oc-
curs within approximately 70–80% of cases as 
a consequence of sympathetic blockade in the 
affected areas of anesthesia, which might cause 
organ and placental hypoperfusion. Acute hypo-
tension reduces cerebral perfusion, which leads 
to transient ischemia and activates the vomiting 
center [3–6]. Fall in CO reduces oxygen deliv-
ery to organs and tissues, results in buildup of 
oxygen debt, causing complications after SA [7, 
8, 9]. Other side effects of hypotension during 
SA are nausea, vomiting, dizziness, respiratory 
problems, and fetal acidosis [10, 11]. 
The most commonly used drugs for hemo-
dynamic optimization during cesarean section 
are ephedrine and phenylephrine [6, 11, 12]. 
Ephedrine leads to greater venoconstriction 
than arteriolar constriction, increases BP, HR, 
improves venous return (preload), increases CO, 
and restores uterine perfusion [13]. Ephedrine 
may cause tachyphylaxis, and is associated 
with increased risk of fetal acidosis [11, 13]. 
Phenylephrine increases venoconstriction and 
arterial constriction, which increases BP, results 
in venous tone increase and favors venous re-
turn (preload) and increases SVR [13–16].
The main goal of this study was to deter-
mine and compare the efficacy and safety of 
preemptive infusion protocols of ephedrine and 
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phenylephrine not only on hypotension prevention but 
also the associated hemodynamic changes during SA for 
cesarean section. Our hypothesis was that the protocol of 
application of these drugs is of importance for hemody-
namic stability and that application of the given doses of 
ephedrine and phenylephrine infusion prevents hypoten-
sion during the planned caesarean section in SA. 
METHODS
This study was designed as prospective and randomized 
and was approved by the ethics committee of Dr Dragiša 
Mišović – Dedinje University Hospital Center, Belgrade, 
Serbia, with the protocol no. 01-5293/23, on April 28, 
2017. This study included 60 patients (from June 25, 2017 
to April 25, 2018) divided randomly into Group P and 
Group E. The patients gave written informed consent to 
participate in the study. Inclusion criteria were as follows: 
patients aged between 18 and 40, American Society of 
Anesthesiologists (ASA) 1 or 2 physical status, and single 
fetus. Exclusion criteria were as follows: less than 36 weeks 
gestation, presence of cardiac, vascular, or neural diseases, 
body weight under 50 kg or greater than 100 kg, height 
under 150 cm, and presence of contraindications for SA.
Protocol P Group
Two minutes before the administration of SA, Group P 
received 25 μg/min. of phenylephrine infusion and this 
was continued at 25 μg/min. for the next three minutes. If 
SBP was unchanged or reduced, the infusion resumed at 
the same rate. If SBP was greater than 20% below baseline, 
patients received a rescue bolus of 50 μg phenylephrine 
intravenously (iv). If bradycardia occurred together with 
SBP less than 20% below baseline, the infusion of phen-
ylephrine was continued at 25 µg/min., and 0.5 mg atro-
pine was administered iv. If bradycardia occurred with SBP 
equal to or higher than baseline, phenylephrine infusion 
was discontinued. If SBP exceeded 20% of the baseline, the 
infusion of phenylephrine was discontinued. 
Protocol E group
Group E patients received ephedrine immediately after SA 
injection at a dose of 5 mg/min. for the first three minutes. 
The same dose was continued where SBP was unchanged 
or lower than the baseline. If SBP decreased more than 
20% of baseline, a rescue bolus dose of 5 mg ephedrine 
was given iv. Where SBP was greater than 20% of the base-
line, ephedrine infusion was discontinued. Both infusions 
were administered via infusion pump Argus 600S (Argus 
Medical, Heimberg, Switzerland).
Bradycardia was defined as a HR under 60 beats per 
minute while hypotension was defined as a reduction in 
SBP greater than 20% of baseline. Hypertension represents 
increase of SBP greater than 20% above the baseline.
All the patients received 50 mg of ranitidine iv and were 
preloaded with 500 ml of Hartmann’s solution. During the 
cesarean section the infusion of Hartmann’s solution was 
resumed. BP, HR, electrocardiogram, and oxygen satura-
tion were recorded using the DASH® 4000 monitor (GE 
Medical Systems Information Technologies Inc., Chicago, 
IL, USA). BP was measured automatically at three-minute 
intervals. Pre-induction values of BP, HR, CO, SV, and SVR 
were recorded with continuous non-invasive hemodynam-
ic monitoring LiDCO RapidV2CNAP (LiDCO Ltd, London, 
UK) and the parameters were measured continuously up to 
the end of the surgical procedure. LIDCO RapidV2CNAP 
contains a module for non-invasive continuous monitoring 
of arterial pressure using a double finger cuff. The Pulse 
COR is a pulse pressure algorithm that calculates SV values 
by the detection of variations in arterial pulse, from the BP 
waveform using pulse power analysis pressure. It provides 
a nominal value for SV, CO and SVR using patient demo-
graphic data of height, weight, and age. SA was given in 
the sitting position using a “pencil point” spinal needle of 
25G (Pencan® B.Braun, Melsungen, Germany). The patients 
received bupivacaine-spinal 0.5% 2–2.2 ml in the L3–L4 
intervertebral space. The patients were then returned to 
the previous supine position with the operating table tilted 
to the left side by 15°. 
Umbilical vein blood gas analyses were performed for 
acidity (pH), partial oxygen pressure (PO2), partial car-
bon dioxide pressure (PCO2), and base excess (BE). Apgar 
score at the first and fifth minute was recorded for each 
newborn. The times from spinal injection to baby delivery 
and from SA until the end of surgery were also recorded.
For statistical analysis we used Kolmogorov–Smirnov 
test to examine distribution, then parametric Student’s 
t-test for two independent groups’ comparison, the 
Wilcoxon signed-rank test for paired groups, and χ² test 
for frequency distribution analysis, using SPSS Version 
19.0 (IBM Corp., Armonk, NY, USA). Before the beginning 
of the study, we performed the statistical power of study 
analysis, and our sample size was sufficient at power of 
80%; p < 0.05 was considered significant.
RESULTS
Demographic characteristics and medical history of the 
patients are presented in Table 1. The body weight and 
height were higher in Group E (p = 0.002, p = 0.086, re-
spectively, Student’s t-test, Table 1). Changes in the mean 
values of hemodynamic parameters between the groups 
were analyzed before (baseline), and at the time of vaso-
pressor infusion (Table 2). 
Mean baseline values of the hemodynamic parameters 
were not significantly different between the two groups 
(baseline values, pEP, Table 2). The mean values SBP, DBP, 
CO, SV, SVR, and HR changed significantly during the 
ephedrine and phenylephrine infusions (pEP < 0.001, 
Student’s t-test, Table 2).
During the infusion, the mean values of SBP, DBP, CO, 
SV, and HR were significantly higher in the Group E com-
pared to Group P, while the mean SVR was significantly 
lower in the Group E compared to the Group P (Table 2).
Vukotić D. A. et al.
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During the ephedrine infusion, the mean DBP was 
significantly lower compared to the baseline values 
(p12 = 0.005, Wilcoxon’s test, Table 2). Mean values of 
CO and SV were significantly higher during ephedrine 
infusion compared to the baseline values (p12 < 0.001, 
Wilcoxon’s test, Table 2); while SVR was significantly lower 
(p12 < 0.001, Wilcoxon’s test, Table 2). 
In Group P, mean values of CO and SVR were not sig-
nificantly changed during the infusion compared to the 
baseline values. During phenylephrine infusion, the mean 
SBP was lower than baseline (p12 = 0.006, Wilcoxon’s test, 
Table 2), as was DBP (p12 < 0.001, Wilcoxon’s test, Table 
2). SV was significantly increased compared with baseline 
(p12 = 0.001, Wilcoxon’s test, Table 2). HR was significant-
ly higher in Group E compared to Group P (pEP < 0.001, 
Student’s t-test, Table 2), and significantly lower than the 
baseline in Group P (p12 < 0.001, Wilcoxon’s test, Table 2). 
During the first 5–6 minutes following SA and vaso-
pressor administration until skin incision, mean SBP val-
ues were similar in Groups E and P. During the delivery, 
and at the fifth and 10th minute after delivery, and up to 
the end of the procedure, significantly higher mean SBP 
values were recorded in Group E compared to Group P 
(p < 0.001, Figure 1A). 




Age (year) 32 (4) 31 (4) 0.335
Weight (kg) 83 (10) 75 (9) 0.002*
Height (cm) 170 (6) 167 (6) 0.086
Gestational age (weeks) 39 (38–40) 39 (38–40) 0.942
Number of previous deliveries 2 (1–3) 2 (1–3) –
ASA physical status I 18 (62%) 18 (58%)
0.752
ASA physical status II 11 (38%) 13 (42%)
E – ephedrine; P – phenylephrine; ASA – American Society  
of Anesthesiologists physical status 
*significant p < 0.05, mean (sd), median (min–max. range), n (%),  
Student’s t-test, χ² test
















SBP (mmHg) 122 (12) 121 (12) 0.828 122 (21) 114 (15) < 0.001* 0.938 0.006*
DBP (mmHg) 74 (9) 73 (11) 0.685 66 (15) 61 (15) < 0.001* 0.005* < 0.001*
CO (L/min) 8 (2) 8 (2.2) 0.645 11 (3.7) 9 (3.5) < 0.001* < 0.001* 0.424
SV (mL) 91 (26) 88 (22) 0.668 111 (36) 110 (38) < 0.001* 0.002* 0.001*
SVR (dyn s/cm5) 878 (204) 852 (233) 0.643 671 (291) 777 (366) < 0.001* < 0.001* 0.253
HR (bpm) 93 (23) 97 (18) 0.444 97 (21) 83 (16) < 0.001* 0.333 < 0.001*
SBP – systolic blood pressure; DBP – diastolic blood pressure; CO – cardiac output; SV – stroke volume; SVR – systemic vascular resistance; HR – heart rate;  
p12 – baseline values compared with values during vasopressor infusion in the respective group 
*significant p < 0.05, mean (sd) Student’s t test
Figure 1. Changes in hemodynamic parameters; comparison to baseline values, and values after spinal anesthesia/after administration 
of vasopressors; SBP-1A – systolic blood pressure; ∆SBP-1B – average changes of systolic blood pressure; DBP-1C – diastolic blood 
pressure; T0 – start of infusion P; T1 – spinal anesthesia (both groups) and start of ephedrine infusion; T2 – skin incision (both groups); T3 
– delivery (both groups); T4 – five minutes after delivery; T5 – 10 minutes after delivery; T6 – 20 minutes after delivery; T7 – end of surgery
*significant p-values
Effects of preemptive infusions of ephedrine and phenylephrine on hemodynamic parameters during spinal anesthesia for cesarean section
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In Group P, except in the first few minutes, SBP was 
lower than baseline. The largest decrease in SBP was seen 
after 8–9 minutes of phenylephrine infusion, but average 
values were only about 10 mmHg lower than baseline 
(Figure 1B). There was a decrease of SBP in Group E be-
tween 3–13 minute up to 6.5 mmHg (Figure 1B). Mean 
values of DBP in both groups were lower than basal levels 
(Figure 1C).
No significant differences in the incidence of hypoten-
sive and hypertensive episodes were detected, and the aver-
age minimum and maximum SBP were similar between 
groups (Figure 2).
Mean CO values in Group E were consistently higher 
than baseline after SA and up to the end of the surgical 
procedure. In Group P, mean CO values were higher than 
baseline only up to the 36th minute (Figure 3A). After SA, 
during the second minute, mean values of CO in Group 
E increased significantly compared to the baseline, and 
compared to Group P (p < 0.001, Figure 3A).
After delivery and up to the end of the procedure, low-
er mean Group P CO values were recorded compared to 
those in Group E (Figure 3A). However, mean Group P CO 
values were similar to baseline values. After the 36th min-
ute, (20 minutes away from delivery), and up to the end 
Figure 3. Changes in hemodynamic parameters, before (baseline) and after spinal anesthesia/after administration of 
vasopressors; CO-3A – cardiac output; SV-3B – stroke volume; SVR-3C – systemic vascular resistance; HR-3D – heart 
rate; T0 – start of phenylephrine infusion; T1 – spinal anesthesia (both groups) and start of ephedrine infusion; T2 – 
skin incision (both groups); T3 – delivery (both groups); T4 – five minutes after delivery; T5 – 10 minutes after delivery; 
T6 – 20 minutes after delivery; T7 – end of operation;
*significant p-values
Figure 2. Incidence of hypotension/hyper-
tension and mean minimum/maximum sys-
tolic arterial pressure; SBP – systolic blood 
pressure; bSBP – baseline systolic blood 
pressure
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of the procedure, mean values of Group P CO decreased 
compared with baseline. In Group E, CO was significantly 
higher up to the end of the procedure compared with base-
line and Group P, (p < 0.001, Figure3A).
Both vasopressors increased SV. In Group E, SV in-
creased significantly after SA, with the addition of ephed-
rine infusion in the second minute (p < 0.001, Figure 3B). 
During skin incision and delivery, SV was significantly 
higher in Group P compared to Group E (p < 0.001, Figure 
3B). From that point on, Group E had higher SV than 
Group P until the end of the procedure. 
SVR values were lower than baseline in both groups 
(Figure 3C).
After five minutes of infusion, Group E’s HR was in-
creased above baseline up to 20th minute. After 24th min, 
mean HR of Group E was below baseline, but it was con-
sistently higher than mean HR of Group P (Figure 3D). 
HR was higher at skin incision and delivery in Group E 
(p < 0.001, Figure 3D). Mean Group 
P HR was below baseline from the 
fifth minute up to the end of the 
procedure. 
Mean values of vasopressors in-
fusion duration were significantly 
longer (p < 0.001, Student’s t-test, 
Table 3) in Group P compared with 
Group E.
Incidence of nausea and vom-
iting were similar in both groups. 
The administration of atropine 
was significantly higher in Group 
P (p = 0.029, χ2 test, Table 3).
Umbilical venous pH was lower 
than 7.2 in one case in Group E. 
However, the mean pH values in 
both groups were identical (7.36). 
No newborn had Apgar score lower 
than 8 in the first minute, and mean 
values of Apgar score were similar 
between groups. Gas analysis of um-
bilical vein showed no significant 
differences between Groups E and P.
DISCUSSION
In our study, after SA, CO values 
increased along with concomitant 
increase of HR and SV. Liu et al. 
[17] detected a significant decrease 
in SVR and an increase in CO after 
SA both before administration of 
phenylephrine and before hypoten-
sion occurred. 
In our study, phenylephrine in-
fusion was introduced two minutes 
prior to administration of SA. This 
was followed by an increase in CO 
following SA, as noted above, but 
these changes were significantly lower than in Group E 
where ephedrine infusion was given immediately after SA. 
With both phenylephrine and ephedrine, the drop in SBP 
did not exceed 20% and the changes were relatively minor. 
We have shown that patients from Group E had signifi-
cantly higher SBP, DBP, CO, SV, and HR, but lower SVR 
than in Group P. Similarly, Gunda et al. [18] in their study 
showed that HR was also significantly higher using ephed-
rine vs. phenylephrine. However, they used a single bolus 
dose of 5 mg of ephedrine or 100 μg of phenylephrine, 
but both were administered only after the occurrence of 
hypotension. Furthermore, the same authors did not detect 
significant differences in SBP (although slightly higher in 
Group P than in Group E) [18].
Allen et al. [19] investigated four groups of patients who 
received different doses of prophylactic fixed-rate phenyl-
ephrine infusions. In the groups that received 25 μg/min. 
and 50 μg/min. P, SBP was higher than 80% of baseline and 
Table 3. Intraoperative characteristics, umbilical vein gases and Apgar scores
Variables Group E(n = 29)
Group P
(n = 31) p
Intraoperative characteristics
Time from spinal anesthesia to the end (min) 49 (8) 51 (9) 0.291
Duration of I–D (min) 15 (3) 15 (3) 0.982
Vasopressor infusion duration (min) 23 (6) 50 (15) < 0.001**
Sensor block level before skin incision T5 (T4–T6) T5 (T4–T6) -
Modified Bromage score for motor block 3 (3–4) 3 (3–4) -





dose 0.05–0.15 µg 0.887
Number of rescue bolus doses 13 11 -
Number of rescue bolus doses before 
delivery 10 7 -
Number of rescue bolus doses after delivery 3 4 -
Mean doses of vasopressors (mg) 49.3 (9.3) 1.3 (0.4) -
Total fluid-crystalloid (ml) 1551 (244) 1419 (291) 0.061
Incidence of nausea
Yes 7 (24%) 3 (10%)
0.133
No 22 (76%) 28 (90%)
Incidence of vomiting
Yes 1 (3%) 0 (0%)
0.297
No 28 (97%) 31 (100%)
Medicaments
Atropine
Yes 1 (3%) 7 (23%)
0.029*
No 28 (97%) 24 (77%)
Metoclopramide
Yes 7 (24%) 3 (10%)
0.133
No 22 (76%) 28 (90%)
Umbilical vein gases and Apgar scores
pH 7.36 (7.14, 7.49) 7.36 (7.29, 7.45) 0.668
PO2 (mmHg) 27.3 (24.4, 30.5) 27.7 (26.1, 28.8) 0.657
PCO2 (mmHg) 37.3 (32.7, 41.8) 38.2 (32.6, 42.6) 0.706
BE (mEq/L) -3.8 (-4.7, -1.6) -2.6 (-4.0, -1.1) 0.122
Apgar first minute 8.97 (0.19) 8.90 (0.30) 0.342
Apgar fifth minute 9.93 (0.26) 9.87 (0.34) 0.447
I–D – time from the induction of spinal anesthesia to delivery of the baby; pH – acidity; PO2 – partial oxygen 
pressure; PCO2 – partial carbon dioxide pressure; BE – base excess 
*significant p < 0.05, mean (sd), n (%), Students t-test, χ2 test, pH, PO2, PCO2, BE median (min., max. range), 
Apgar mean (sd); Modified Bromage score: 1 – able to raise legs above the table; 2 – able to flex knees;  
3 – able to move feet only; 4 – no movement in legs or feet
Effects of preemptive infusions of ephedrine and phenylephrine on hemodynamic parameters during spinal anesthesia for cesarean section
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in the groups that received 75 μg/min. and 100 μg/min. the 
incidence of hypertension was increased [19]. Also, our 
study showed that patients who received phenylephrine 
at a dose of 25 μg/min., SBP remained greater than 80% 
of baseline.
Langesæter et al. [20] examined the effects of two dif-
ferent intrathecal doses of bupivacaine, with or without 
iv phenylephrine infusion on hemodynamic parameters. 
This study showed that a low dose of prophylactic phen-
ylephrine infusion (0.25 µg/kg per min.) provided the 
best hemodynamic stability [20]. In our study, patients in 
Group P received 10 mg spinal bupivacaine and prophy-
lactic phenylephrine infusion (25 µg/min.) two minutes 
prior to SA and were also quite effective.
Mon et al. [21] in their study examined the effects of 
ephedrine and phenylephrine infusion on hemodynamics. 
In Group P, CO was significantly lower than the baseline in 
the 10th and 15th min. after application of SA, in contrast 
with Group E, in which CO values were not significantly 
changed [21]. Ephedrine administration was associated 
with significantly more cases of fetal acidosis despite good 
SBP control and increased CO [21]. Our study showed that 
after the initial increase in CO in both groups, there was 
a reduction in CO in the Group P, but values below the 
baseline were detected only from 36th minute up to the 
end of the surgery, which might be important for fetal out-
come. It should be recalled that the dose of phenylephrine 
in our study was four times lower than in the previously 
described and continued for a longer time. Unlike in the 
previously mentioned study, where no significant changes 
in SV were detected, in our study SV was increased in both 
groups [21]. Numerous studies have shown associations 
between HR and CO, as was the case here [14].
The lowest average HR values in Group P were recorded 
in the 37th minute of phenylephrine infusion, which co-
incides with the time when CO in the same group drops 
below baseline values. A total of seven patients in Group 
P had HR < 60 and received atropine (five of them before 
delivery), which may be associated with the administration 
of seven phenylephrine rescue doses before the birth of a 
baby. Also, other authors have found higher incidence of 
bradycardia in patients receiving phenylephrine than those 
receiving ephedrine [22].
Ngan et al. [23] showed that prophylactic phenyleph-
rine infusion of 100 µg/min. decreased the incidence of 
hypotension during SA for cesarean delivery compared 
with control group, who received bolus phenylephrine at 
100 µg after each event of SBP < 80% of baseline. Results in 
our study, using four times smaller dose of phenylephrine 
infusion, show that reactive hypertension was recorded in 
29% of the patients.
Although other studies reported higher incidences of 
nausea and vomiting in groups on ephedrine, we did not 
detect significant differences between Group E and Group 
P [10, 19]. We are of the opinion that not only type of va-
sopressor, but the protocol of administration and dosage 
significantly influences the incidence of side effects.
CONCLUSION
In this study, SBP remained in the normal range during 
infusion in both groups, which indicated that ephedrine 
and phenylephrine are both effective. Both vasopressors 
had similar effects on newborns. Continuous monitor-
ing of hemodynamic parameters, with a well-defined ad-
ministration protocol and dosing regimen are considered 
important for a favorable outcome, as shown in this study.
Conflict of interest: None declared.
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САЖЕТАК
Увод/Циљ Током спиналне анестезије (СА) за царски рез 
долази до значајних хемодинамских промена, као и до хи-
потензије. 
Циљ ове студије био је да се утврдe и упоредe ефикасност 
и безбедност преемптивних инфузионих протокола два нај-
чешће коришћена вазопресора, ефедрина (група Е, n = 29) 
и фенилефрина (група П, n = 31), не само у циљу превенције 
хипотензије већ ради утврђивања њиховог утицаја на хемо-
динамске параметаре, као што су ударни волумен и минутни 
волумен, коришћењем континуираног неинвазивног хемо-
динамског монитора.
Методе Инфузија ефедрина је укључена у дози од 5 mg/min., 
одмах после СА. Инфузија фенилефрина је укључена у дози 
од 25 μg/min., на два минута пре СА. 
Резултати У групи Е средње вредности систолног крвног 
притиска и срчана фреквенција нису се значајно проме-
нилe у односу на базалне вредности. Минутни волумен је 
био значајно виши (p < 0,001), док је системски васкуларни 
отпор био значајно нижи у односу на базалне вредности 
(p < 0,001). У групи П средње вредности систолног крвног 
притиска и дијастолног крвног притиска биле су значајно 
ниже у односу на базалне вредности (p = 0,006, односно 
p < 0,001). Средње вредности систолног крвног притиска, 
дијастолног крвног притиска, минутног волумена, ударног 
волумена, системског васкуларног отпора и срчане фрек-
венције су се статистички значајно разликовале између 
група Е и П (p < 0,001). Гасне анализе венске умбиликалне 
крви и оцена Апгар су биле сличне у обе групе.
Закључак Вазопресори ефедрин и фенилефрин су веома 
делотворни у превенцији хипотензије током СА.
Кључне речи: царски рез; спинална анестезија; ефедрин; 
фенилефрин; хипотензија; хемодинамски параметри
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